Giuseppe Mario Bentivenga

Employment

• University of Bologna
  2021 - Present

Education

• University of Bologna Master degree in Medicine and Surgery
  2015 - 2021

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Rapidly progressive dementia with parkinsonism in the Italian CJD Registry: underlying pathology and clinical-biomarker clues for differential diagnosis
  Parkinsonism & Related Disorders 2026 DOI: 10.1016/j.parkreldis.2026.108413
  +Save
• Clinical correlates of a negative cerebrospinal fluid α-synuclein seed amplification assay result in Parkinson’s disease
  npj Parkinson's Disease 2026 DOI: 10.1038/s41531-026-01346-3
  +Save
• Prevalence and clinical effects of Lewy Body pathology in non-prion rapidly progressive dementias: a retrospective cohort study
  Alzheimer's Research & Therapy 2026 DOI: 10.1186/s13195-026-02004-9
  +Save
• Analytical and clinical validation of a novel proximity extension assay-based plasma biomarker panel in a cohort of prevalent neurodegenerative dementias
  Alzheimer's Research & Therapy 2026 DOI: 10.1186/S13195-026-02142-0
  +Save
• The Phenotypic Spectrum of Sporadic Creutzfeldt‐Jakob Disease Cortical Subtype
  Annals of Neurology 2025 DOI: 10.1002/ana.78117
  +Save
• Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival
  Acta Neuropathologica Communications 2025 DOI: 10.1186/s40478-025-02168-9
  +Save
• Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease
  Alzheimer's & Dementia 2025 DOI: 10.1002/alz.14422
  +Save
• Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?
  Alzheimer's Research & Therapy 2024 DOI: 10.1186/s13195-024-01565-x
  +Save
• Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
  Giuseppe Mario Bentivenga, Angela Mammana, Simone Baiardi +8 more
  Acta Neuropathologica 2024 DOI: 10.1007/s00401-023-02663-0
  +Save
• Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia
  Giuseppe Mario Bentivenga, Simone Baiardi, Andrea Mastrangelo +6 more
  International Journal of Molecular Sciences 2024 DOI: 10.3390/ijms25105106
  +Save
• Levels of plasma brain‐derived tau and p‐tau181 in Alzheimer's disease and rapidly progressive dementias
  Alzheimer's & Dementia 2024 DOI: 10.1002/alz.13516
  +Save
• Rapidly progressive dementia due to intravascular lymphoma: A prion disease reference center experience
  Giuseppe Mario Bentivenga, Simone Baiardi, Lorenzo Righini +4 more
  European Journal of Neurology 2024 DOI: 10.1111/ene.16068
  +Save
• High diagnostic performance of plasma and cerebrospinal fluid beta‐synuclein for sporadic Creutzfeldt–Jakob disease
  Samir Abu‐Rumeileh, Steffen Halbgebauer, Giuseppe Mario Bentivenga +9 more
  Annals of Clinical and Translational Neurology 2023 DOI: 10.1002/acn3.51873
  +Save
• Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias
  Alzheimer's Research & Therapy 2023 DOI: 10.1186/s13195-023-01300-y
  +Save
• Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
  Simone Baiardi, Corinne Quadalti, Angela Mammana +12 more
  Alzheimer's Research & Therapy 2022 DOI: 10.1186/s13195-022-01093-6
  +Save